The clinicopathological characteristics of CCA patients, including age, sex, tumor staging, tumor size, tumor node metastasis (TMN), histological grading, and chemotherapy with respect to the level of LC3 and p62 expression in cancer cells and of IL-6 in CAFs are presented in Table 1. This evidence concerns the gene MAP1LC3A and neoplasm.